New terbinafine supplier secured
18 Dec 2024 //
PHARMAWEB
Moberg Reports Phase 3 Data, Regains EU Rights To MOB-015
10 Dec 2024 //
PRESS RELEASE
Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study
24 Jun 2020 //
PRNEWSWIRE
Moberg inks deal with Taisho for anti-fungal candidate
03 Oct 2019 //
BIOSPECTRUM ASIA